Advertisement
Screener

EyePoint, Inc. (EYPT) Proceeds from Sale and Maturity of Marketable Securities

EyePoint, Inc. Proceeds from Sale and Maturity of Marketable Securities

EyePoint, Inc. (EYPT) reported Proceeds from Sale and Maturity of Marketable Securities of $145.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-05

  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $75.00M, a 27.54% decline year-over-year.
  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $70.00M, a 11.64% decline year-over-year.
  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $75.00M, a 9.49% increase year-over-year.
  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $66.00M, a 1.49% decline year-over-year.
  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for fiscal 2025 was $323.73M, a 76.90% increase from fiscal 2024.
  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for fiscal 2024 was $183.00M, a 231.02% increase from fiscal 2023.
  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for fiscal 2023 was $55.28M, a 55.42% decline from fiscal 2022.
  • EyePoint, Inc. proceeds from sale and maturity of marketable securities for fiscal 2022 was $124.00M.
Period endProceeds from Sale and Maturity of Marketable Securities 3 monthProceeds from Sale and Maturity of Marketable Securities 6 monthProceeds from Sale and Maturity of Marketable Securities 9 monthProceeds from Sale and Maturity of Marketable Securities 12 month
2026-06-30$75.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$145.00M
10-Q · filed 2026-08-05
$220.00M
derived: sum of 3 quarters · filed 2026-08-05
$286.00M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$70.00M
10-Q · filed 2026-05-07
$145.00M
derived: sum of 2 quarters · filed 2026-05-07
$211.00M
derived: sum of 3 quarters · filed 2026-05-07
$314.50M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$75.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$141.00M
derived: sum of 2 quarters · filed 2026-03-05
$244.50M
derived: sum of 3 quarters · filed 2026-08-05
$323.73M
10-K · filed 2026-03-05
2025-09-30$66.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$169.50M
derived: sum of 2 quarters · filed 2026-08-05
$248.72M
10-Q · filed 2025-11-06
$317.23M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$103.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$182.72M
10-Q · filed 2026-08-05
$251.22M
derived: sum of 3 quarters · filed 2026-08-05
$318.23M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$79.22M
10-Q · filed 2026-05-07
$147.72M
derived: sum of 2 quarters · filed 2026-05-07
$214.72M
derived: sum of 3 quarters · filed 2026-05-07
$240.22M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$68.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$135.50M
derived: sum of 2 quarters · filed 2026-03-05
$161.00M
derived: sum of 3 quarters · filed 2026-03-05
$183.00M
10-K · filed 2026-03-05
2024-09-30$67.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$92.50M
derived: sum of 2 quarters · filed 2025-11-06
$114.50M
10-Q · filed 2025-11-06
$117.50M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$25.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$47.50M
10-Q · filed 2025-08-07
$50.50M
derived: sum of 3 quarters · filed 2025-08-07
$50.50M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$22.00M
10-Q · filed 2025-05-08
$25.00M
derived: sum of 2 quarters · filed 2025-05-08
$25.00M
derived: sum of 3 quarters · filed 2025-05-08
$41.78M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$3.00M
derived: sum of 2 quarters · filed 2025-03-06
$19.78M
derived: sum of 3 quarters · filed 2025-03-06
$55.28M
10-K · filed 2025-03-06
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$16.78M
derived: sum of 2 quarters · filed 2024-11-07
$52.28M
10-Q · filed 2024-11-07
$99.28M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$16.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$52.28M
10-Q · filed 2024-08-08
$99.28M
derived: sum of 3 quarters · filed 2024-08-08
$140.28M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$35.50M
10-Q · filed 2024-05-09
$82.50M
derived: sum of 2 quarters · filed 2024-05-09
$123.50M
derived: sum of 3 quarters · filed 2024-05-09
$153.50M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$47.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$88.00M
derived: sum of 2 quarters · filed 2024-03-08
$118.00M
derived: sum of 3 quarters · filed 2024-03-08
$124.00M
10-K · filed 2024-03-08
2022-09-30$41.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$71.00M
derived: sum of 2 quarters · filed 2023-11-03
$77.00M
10-Q · filed 2023-11-03
$77.00M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30$30.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$36.00M
10-Q · filed 2023-08-04
$36.00M
derived: sum of 3 quarters · filed 2023-08-04
2022-03-31$6.00M
10-Q · filed 2023-05-04
$6.00M
derived: sum of 2 quarters · filed 2023-05-04
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
$0.00
10-K · filed 2023-03-10
2021-09-30$0.00
10-Q · filed 2022-11-04
2021-03-31$0.00
10-Q · filed 2022-05-06
2018-12-31$0.00
10-KT · filed 2019-03-18
2018-06-30$0.00
derived: 10-KT 12 month − 10-Q 9 month · filed 2019-03-18
$0.00
derived: sum of 2 quarters · filed 2019-03-18
$0.00
derived: sum of 3 quarters · filed 2019-03-18
$0.00
10-KT · filed 2019-03-18
2018-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10
$0.00
derived: sum of 2 quarters · filed 2018-05-10
$0.00
10-Q · filed 2018-05-10
$2.50M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
$0.00
10-Q · filed 2018-02-08
$2.50M
derived: sum of 3 quarters · filed 2020-03-16
$5.85M
derived: sum of 4 quarters · filed 2020-03-16
2017-09-30$0.00
10-Q · filed 2017-11-08
$2.50M
derived: sum of 2 quarters · filed 2020-03-16
$5.85M
derived: sum of 3 quarters · filed 2020-03-16
$11.24M
derived: sum of 4 quarters · filed 2020-03-16
2017-06-30$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$5.85M
derived: sum of 2 quarters · filed 2020-03-16
$11.24M
derived: sum of 3 quarters · filed 2020-03-16
$18.74M
10-K · filed 2020-03-16
2017-03-31$3.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10
$8.74M
derived: sum of 2 quarters · filed 2018-05-10
$16.24M
10-Q · filed 2018-05-10
2016-12-31$5.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
$12.89M
10-Q · filed 2018-02-08
2016-09-30$7.50M
10-Q · filed 2017-11-08
2016-06-30$13.17M
10-KT · filed 2019-03-18
2015-06-30$3.65M
10-K · filed 2017-09-13
2014-03-31$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14
$1.90M
derived: sum of 2 quarters · filed 2014-05-14
$3.35M
10-Q · filed 2014-05-14
$5.65M
derived: sum of 4 quarters · filed 2014-05-14
2013-12-31$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-12
$2.85M
10-Q · filed 2014-02-12
$5.15M
derived: sum of 3 quarters · filed 2014-02-12
$8.90M
derived: sum of 4 quarters · filed 2014-05-14
2013-09-30$1.45M
10-Q · filed 2013-11-13
$3.75M
derived: sum of 2 quarters · filed 2013-11-13
$7.50M
derived: sum of 3 quarters · filed 2014-05-14
$12.18M
derived: sum of 4 quarters · filed 2014-05-14
2013-06-30$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27
$6.05M
derived: sum of 2 quarters · filed 2014-05-14
$10.73M
derived: sum of 3 quarters · filed 2014-05-14
$14.18M
10-K · filed 2013-09-27
2013-03-31$3.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14
$8.43M
derived: sum of 2 quarters · filed 2014-05-14
$11.88M
10-Q · filed 2014-05-14
$15.13M
derived: sum of 4 quarters · filed 2014-05-14
2012-12-31$4.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-12
$8.14M
10-Q · filed 2014-02-12
$11.39M
derived: sum of 3 quarters · filed 2014-02-12
$16.84M
derived: sum of 4 quarters · filed 2014-02-12
2012-09-30$3.45M
10-Q · filed 2013-11-13
$6.70M
derived: sum of 2 quarters · filed 2013-11-13
$12.15M
derived: sum of 3 quarters · filed 2013-11-13
$15.35M
derived: sum of 4 quarters · filed 2013-11-13
2012-06-30$3.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27
$8.70M
derived: sum of 2 quarters · filed 2013-09-27
$11.90M
derived: sum of 3 quarters · filed 2013-09-27
$15.30M
10-K · filed 2013-09-27
2012-03-31$5.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14
$8.65M
derived: sum of 2 quarters · filed 2013-05-14
$12.05M
10-Q · filed 2013-05-14
$15.54M
derived: sum of 4 quarters · filed 2013-09-27
2011-12-31$3.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-08
$6.60M
10-Q · filed 2013-02-08
$10.09M
derived: sum of 3 quarters · filed 2013-09-27
$12.45M
derived: sum of 4 quarters · filed 2013-09-27
2011-09-30$3.40M
10-Q · filed 2012-11-09
$6.89M
derived: sum of 2 quarters · filed 2013-09-27
$9.25M
derived: sum of 3 quarters · filed 2013-09-27
$9.70M
derived: sum of 4 quarters · filed 2013-09-27
2011-06-30$3.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27
$5.85M
derived: sum of 2 quarters · filed 2013-09-27
$6.30M
derived: sum of 3 quarters · filed 2013-09-27
$6.60M
10-K · filed 2013-09-27
2011-03-31$2.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10
$2.81M
derived: sum of 2 quarters · filed 2012-05-10
$3.11M
10-Q · filed 2012-05-10
2010-12-31$450.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-09
$750.00K
10-Q · filed 2012-02-09
2010-09-30$300.00K
10-Q/A · filed 2011-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15